1
Clinical Trials associated with Autologous tumor lysate-loaded mature dendritic cells (Heinrich-Heine-Universität Düsseldorf) / Active, not recruitingPhase 2 Phase II Trial of Vaccination with Lysate-loaded, Mature Dendritic Cells Integrated Into Standard Radiochemotherapy in Newly Diagnosed Glioblastoma
The primary objective of the study is to determine whether overall survival of newly diagnosed glioblastoma patients treated with lysate-loaded, mature dendritic cell vaccines as add-on to the standard of care consisting of resection, radiotherapy with concomitant temozolomide chemotherapy and subsequent adjuvant temozolomide chemotherapy is superior to the treatment with the standard of care alone.
100 Clinical Results associated with Autologous tumor lysate-loaded mature dendritic cells (Heinrich-Heine-Universität Düsseldorf)
100 Translational Medicine associated with Autologous tumor lysate-loaded mature dendritic cells (Heinrich-Heine-Universität Düsseldorf)
100 Patents (Medical) associated with Autologous tumor lysate-loaded mature dendritic cells (Heinrich-Heine-Universität Düsseldorf)
100 Deals associated with Autologous tumor lysate-loaded mature dendritic cells (Heinrich-Heine-Universität Düsseldorf)